The National Institutes of Health seeks applications for Countermeasures Against Chemical Threats (CounterACT) advanced development cooperative agreements. The mission of the CounterACT program is to develop new and improved medical countermeasures against chemical threats. These include pulmonary agents such as chlorine, industrial chemicals such as cyanide, and nerve agents such as sarin. The focus will be on therapies that can be used after exposure to a chemical threat as opposed to pre-exposure prophylactic treatments. NIH plans to commit about $2.5 million in FY ’08 to fund four to six CounterACT research projects as cooperative agreements. Sol. No. RFA-NS-08-003. Respond by Nov. 9.